Meghan Holdorf

Meghan Holdorf is a seasoned professional in the field of biology with extensive experience in virology and drug discovery. Currently serving as Sr. Director of Biology at Gilead Sciences since December 2018, Meghan has previously held significant roles at Novartis Institutes for BioMedical Research, including Investigator III and Investigator II, where leadership involved managing large teams for virology-focused drug development. With a Ph.D. in Biochemistry and Molecular Biology from Miami University and a B.A. in Biology and Chemistry from Simpson College, Meghan's academic background complements a strong record of research involving transcriptional profiling and chromatin regulation, including notable postdoctoral work at the University of California, San Francisco. Additionally, participation in the M1 Leading at the Front-Line Leadership Development Program underscores leadership capabilities within the industry.